Stock NEOD NEOS AB
Add to a list
To use this feature you must be a member
Log inSign up

Ratings NEOS AB

Equities

NEOD

SE0021615655

Delayed Nasdaq Stockholm
Other stock markets
 07:44:52 2024-07-05 am EDT 		5-day change 1st Jan Change
0.892 SEK -8.79% Intraday chart for NEOS AB -1.55% -59.45%
Jul. 02 NeoDynamics Secures Approval to Delist from Nasdaq First North MT
Jun. 18 Norse Atlantic to Operate Boeing 787 Routes for Neos in Winter MT

Strengths

  • The prospective high growth for the next fiscal years is among the main assets of the company
  • With regards to fundamentals, the enterprise value to sales ratio is at 0.87 for the current period. Therefore, the company is undervalued.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • One of the major weak points of the company is its financial situation.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
NEOS AB Stock NEOS AB
-59.45% 3.04M -
SARTORIUS AG Stock Sartorius AG
-30.43% 15.32B
A
QUIDELORTHO CORPORATION Stock QuidelOrtho Corporation
-57.92% 2.08B
C+
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD. Stock Inner Mongolia Furui Medical Science Co., Ltd.
+20.62% 1.9B -
SHANGHAI MICROPORT EP MEDTECH CO., LTD. Stock Shanghai MicroPort EP MedTech Co., Ltd.
-26.04% 1.23B -
BIOTAGE AB Stock Biotage AB
+23.04% 1.21B
B+
REVENIO GROUP OYJ Stock Revenio Group Oyj
+1.55% 777M -
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD. Stock Shanghai AoHua Photoelectricity Endoscope Co., Ltd.
-37.53% 717M -
CONTEC MEDICAL SYSTEMS CO.,LTD Stock Contec Medical Systems Co.,Ltd
-39.55% 689M -
C-
VAREX IMAGING CORPORATION Stock Varex Imaging Corporation
-29.95% 587M
B+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
-
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
-

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. NEOD Stock
  4. Ratings NEOS AB